EUVIMEDEUVIMED entdecken
Crossref

Afatinib approval for NSCLC brings EGFR TKI story full circle

James P Stevenson

The Journal of Community and Supportive Oncology · 2014

DOI: 10.12788/jcso.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2014. Verfasst von James P Stevenson. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Stevenson, J. P. (2014). Afatinib approval for NSCLC brings EGFR TKI story full circle. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/jcso.0002

Vancouver

Stevenson JP. Afatinib approval for NSCLC brings EGFR TKI story full circle. The Journal of Community and Supportive Oncology. 2014. doi:10.12788/jcso.0002

BibTeX
@article{Stevenson2014,
  author = {Stevenson, James P},
  title = {Afatinib approval for NSCLC brings EGFR TKI story full circle},
  journal = {The Journal of Community and Supportive Oncology},
  year = {2014},
  doi = {10.12788/jcso.0002}
}
Kostenlos starten →